Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

AB+ blood group is more common in alopecia areata patients.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.